PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The right dose for oncology

2013-03-05
(Press-News.org) King Mithridates understood that poison is only as good as the dosage taken. Each day, he ingested small quantities of poison in order to become immunize and escape his court's plotters. Oncologists run up against the same principle when fighting cancer. Sometimes, a small dose of chemotherapy may induce dangerous resistance mechanisms in malignant cells, resulting in relapse. Now, EPFL research published in the journal PLOS ONE reports a tool that could simply and accurately determine the right dose for individual patients.

Dosage, a vital issue

This novel tool, developed by Philippe Renaud's team at EPFL, is based on a very simple principle: a cell's electrical conductivity depends on the level of stress induced by chemotherapy. In broad terms, by measuring a cancerous cell's capacity to conduct electricity, researchers can assess the intensity of the treatment's effect.

"When chemotherapy induces very little stress in cells, particularly after the application of a small dose, there is a problem," says Robert Meissner, a co-author of the study. "Not only is its effect not sufficient to kill the affected cells, but this actually increases the risk of inducing resistance, which will eventually make the treatment ineffective."

This is vital during relapse as cells have already developed resistance mechanisms and sometimes oncologists don't have an effective alternative therapy. Hence, it is fundamental to apply the right dose from the start.

Step towards personalized oncology

The method developed at EPFL could help doctors make more patient-specific decisions. "We fully subscribe to the trend of personalized medicine," explains Philippe Renaud. "By making a simple biopsy, oncologists could test the way a particular patient's cells respond to different types of treatments at various doses."

The tool, which was designed for a clinical environment, provides a simple and fast analysis without affecting the treated cells. Unlike methods based on biomarkers, which kill cells and are extremely strenuous to perform, the EPFL technology could be implemented easily in a medical environment. In fact, scientists have already tested it on malignant breast cells treated with a standard drug, doxorubicin.

The EPFL team is currently in discussion with oncologists to continue jointly developing their procedure. Within a few months, researchers say, a startup company will likely be created to help bring the laboratory work into the hospital setting.

### Researcher Contact: Robert Meissner, EPFL
robert.meissner@epfl.ch
+ 41 216936752 END


ELSE PRESS RELEASES FROM THIS DATE:

Pharmaceutical advertising down but not out

2013-03-05
The pharmaceutical industry has pulled back on marketing to physicians and consumers, yet some enduring patterns persist. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, advertising peaked in 2004, with industry promotion to physicians declining nearly 25 percent by 2010, to $27.7 billion or 9 percent of sales. Similar declines were seen in direct-to-consumer advertising, which remains concentrated among a small number of products. The number of products promoted to providers peaked at over 3,000 in 2004, and declined ...

Accurate water vapor measurements for improved weather and climate models

Accurate water vapor measurements for improved weather and climate models
2013-03-05
Humidity measurements in the atmosphere are of essential importance, since water vapour, as the most important natural greenhouse gas, has a strong influence on the Earth's atmospheric radiation balance and, thus, decisively influences our climate. In addition, water is responsible for meteorological phenomena such as the formation of clouds and precipitation. Hence, the atmospheric water content is an essential measurand in all climate models, but also when it comes to forecasting the weather; this measurand has to be determined with great accuracy if reliable predictions ...

Quality of care measures improve performance

2013-03-05
Public reporting of how physicians and hospitals perform in quality of care measures leads to improved care for patients. A collaborative team of researchers led by Geoffrey C. Lamb, M.D., professor of internal medicine at the Medical College of Wisconsin, published their findings in the March 2013 edition of Health Affairs. The researchers analyzed 14 publicly reported quality of care measures from 2004 to 2009 for the Wisconsin Collaborative for Healthcare Quality, a voluntary consortium of physician groups, and found that physician groups in the collaborative improved ...

Prospective study finds many children with retinoblastoma can safely forego adjuvant chemotherapy

2013-03-05
In this News Digest: Summary of a study being published online March 4, 2013 in the Journal of Clinical Oncology, reporting that in certain children with retinoblastoma, adjuvant chemotherapy can be avoided, without risking disease worsening or relapse. The findings will help decision-making about adjuvant treatment and therapy selection for patients with low- , intermediate-, and high-risk retinoblastoma affecting only one eye Quote for attribution to ZoAnn Eckert Dreyer, MD, American Society of Clinical Oncology Cancer Communications Committee member and pediatric ...

Brain adds cells in puberty to navigate adult world

2013-03-05
The brain adds new cells during puberty to help navigate the complex social world of adulthood, two Michigan State University neuroscientists report in the current issue of the Proceedings of the National Academy of Sciences. Scientists used to think the brain cells you're born with are all you get. After studies revealed the birth of new brain cells in adults, conventional wisdom held that such growth was limited to two brain regions associated with memory and smell. But in the past few years, researchers in MSU's neuroscience program have shown that mammalian brains ...

Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens

2013-03-05
A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants. The study, presented on March 4 at the 20th annual Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, shows that ART administered in early infancy can help curtail the formation of hard-to-treat viral sanctuaries — reservoirs of "sleeper" cells responsible for reigniting infection ...

Discovery of 'executioner' protein opens door to new options for stroke ALS, spinal cord injury

Discovery of executioner protein opens door to new options for stroke ALS, spinal cord injury
2013-03-05
Oxidative stress turns a protein that normally protects healthy cells into their executioner, according to a study released today in the Proceedings of the National Academy of Sciences journal. Alvaro Estevez, an associate professor at the University of Central Florida's College of Medicine, led the multi-university team that made the discovery, which could eventually help scientists develop new therapies to combat a host of conditions from stroke to Lou Gehrig's disease Researchers have long known that oxidative stress damages cells and results in neurodegeneration, ...

'OK' contact lenses work by flattening front of cornea, not the entire cornea...

2013-03-05
Philadelphia, Pa. (March 04, 2013) - A contact lens technique called overnight orthokeratology (OK) brings rapid improvement in vision for nearsighted patients. Now a new study shows that OK treatment works mainly by flattening the front of the cornea, reports a recent study, "Posterior Corneal Shape Changes in Myopic Overnight Orthokeratology", appearing in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. "This study appears ...

UCSB physicists make discovery in the quantum realm

UCSB physicists make discovery in the quantum realm
2013-03-05
(Santa Barbara, Calif.) –– Physicists at UC Santa Barbara are manipulating light on superconducting chips, and forging new pathways to building the quantum devices of the future –– including super-fast and powerful quantum computers. The science behind tomorrow's quantum computing and communications devices is being conducted today at UCSB in what some physicists consider to be one of the world's top laboratories in the study of quantum physics. A team in the lab of John Martinis, UCSB professor of physics, has made a discovery that provides new understanding in the quantum ...

60 percent loss of forest elephants in Africa confirmed

2013-03-05
NEW YORK (EMBARGOED UNTIL March 4, 2013, 5 PM U.S. Eastern Time) — African forest elephants are being poached out of existence. A study just published in the online journal PLOS ONE shows that across their range in central Africa, a staggering 62 percent of all forest elephants have been killed for their ivory over the past decade. "The analysis confirms what conservationists have feared: the rapid trend towards extinction – potentially within the next decade – of the forest elephant," says Dr. Samantha Strindberg of the Wildlife Conservation Society (WCS), one of the ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] The right dose for oncology